Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells

The Journal of Immunology(2020)10.4049/jimmunol.1901234Source: DataRank Database

Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells is a research paper published in The Journal of Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.86)OA: bronzeTopics (57)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Satoshi Ishido ORCID,Laurence C. Eisenlohr ORCID,Paul A. Roche ORCID,Kyungjin Cho ORCID

Live enrichment

PubMed:31996461 PMC:PMC7065958 OpenAlex:https://openalex.org/W3003903153

Intramural NIH HHS

Grant: Z01 BC009404

NIAID NIH HHS

Grant: P30 AI045008

FWCI

0.86

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://www.jimmunol.org/content/jimmunol/204/6/1621.full.pdf

publisherhttps://www.jimmunol.org/content/jimmunol/204/6/1621.full.pdf

publisherhttps://academic.oup.com/jimmunol/article-pdf/204/6/1621/61882220/ji1901234.pdf

journalhttps://doi.org/10.4049/jimmunol.1901234

repositoryhttps://pubmed.ncbi.nlm.nih.gov/31996461

Fields of Study

Immunotherapy and Immune ResponsesImmune Cell Function and InteractionT-cell and B-cell ImmunologyAnimalsAntigen PresentationAntigens, ViralCD4-Positive T-LymphocytesDendritic CellsEndosomesEpitopes, T-LymphocyteGene Knock-In TechniquesGene Knockdown TechniquesGenes, MHC Class IIHistocompatibility Antigens Class IIHybridomasLymphocyte ActivationMiceMice, KnockoutOrthomyxoviridaeUbiquitin-Protein Ligasesrab GTP-Binding Proteinsrab11 GTP-Binding Proteins

MeSH Terms

rab11 GTP-Binding ProteinsAnimalsHistocompatibility Antigens Class IIAntigens, ViralDendritic CellsGenes, MHC Class IIHybridomasLymphocyte ActivationOrthomyxoviridaeEndosomesCD4-Positive T-LymphocytesAntigen PresentationMice, KnockoutEpitopes, T-Lymphocyterab GTP-Binding ProteinsUbiquitin-Protein LigasesMiceGene Knockdown TechniquesGene Knock-In Techniques

Keywords

EndosomeAntigen processingAntigen presentationMHC class ICell biologyMHC class IIEpitopeCross-presentationBiologyMajor histocompatibility complexMHC restrictionAntigenAntigen-presenting cellT cellImmune systemImmunology

Sustainable Development Goals

SDG 0: Decent work and economic growth

Additional file 1 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.24709023.v1figshare

Additional file 1 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.24709023figshare

Additional file 2 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.24709132.v1figshare

Additional file 2 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.24709132figshare

Additional file 3 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647890.v1figshare

Additional file 3 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647890figshare

Additional file 4 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647893.v1figshare

Additional file 4 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647893figshare

Additional file 5 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647896.v1figshare

Additional file 5 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647896figshare

Additional file 6 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647899.v1figshare

Additional file 6 of HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population

10.6084/m9.figshare.26647899figshare